Robert J Bitterman

CIK 1304395 · Chairman, Pres. & CEO · last filed 2026-02-06

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$440.2K

Companies

4

Total Filings

36

Lifetime Open-Market Net

$59.5K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
PHIO Chairman, Pres. & CEO 411,421 $1.07 $440.2K $53.5K 24 2026-02-06
Phio Pharmaceuticals Corp. (PHIOW) Delisted Director 15,826 $0.02 $367 $0 3 2021-03-03
Phio Pharmaceuticals Corp. (RXIIW) Delisted Director 10,440 $0 2 2018-08-03
Phio Pharmaceuticals Corp. (RXII) Delisted Director 44,000 $6.0K 4 2016-02-12

Recent Filings · Page 2 of 4

36 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2024-06-11 PHIO Buy (P) +1,000 $740 EDGAR
2024-06-10 PHIO Buy (P) +1,000 $750 EDGAR
2024-02-27 PHIO Buy (P) +2,500 $2.3K EDGAR
2024-02-22 PHIO Tax (F) −1,804 -$1.4K EDGAR
2023-10-03 PHIO Tax (F) −917 -$1.4K EDGAR
2023-07-05 PHIO Buy (P) +2,000 $5.7K EDGAR
2023-02-22 PHIO Grant (A) +11,000 $0 EDGAR
2022-12-15 PHIO Buy (P) +2,000 $780 EDGAR
2022-12-08 PHIO Buy (P) +2,000 $780 EDGAR
2022-12-06 PHIO Buy (P) +2,000 $860 EDGAR
Showing 1120 of 36
Page 2 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.